nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant action of cholera toxin and pertussis toxin in the induction of IgA antibody response to orally administered antigen
|
Wilson, A.D. |
|
1993 |
11 |
2 |
p. 113-118 6 p. |
artikel |
2 |
Antigenicity, immunogenicity and vaccine efficacy of the galactose-specific adherence protein of Entamoeba histolytica
|
Ravdin, Jonathan I. |
|
1993 |
11 |
2 |
p. 241-246 6 p. |
artikel |
3 |
Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential
|
Redmond, M.J. |
|
1993 |
11 |
2 |
p. 273-281 9 p. |
artikel |
4 |
Avirulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccination
|
Schödel, Florian |
|
1993 |
11 |
2 |
p. 143-148 6 p. |
artikel |
5 |
Basic structural immunogenic peptides having epitopes for HCV; hepatitis C virus recombinant antigen production; DNA sequence; may be used in diagnosis, gene therapy and recombinant vaccine production
|
|
|
1993 |
11 |
2 |
p. 283- 1 p. |
artikel |
6 |
Biodegradable microparticles for oral immunization
|
O'Hagan, D.T. |
|
1993 |
11 |
2 |
p. 149-154 6 p. |
artikel |
7 |
Calendar
|
|
|
1993 |
11 |
2 |
p. 286- 1 p. |
artikel |
8 |
Capsular polysaccharide immunogen of Streptococcus pneumoniae; used as a vaccine against S. pneumoniae infections and associated diseases
|
|
|
1993 |
11 |
2 |
p. 283- 1 p. |
artikel |
9 |
Circulating cellular immune response to oral immunization of humans with cholera toxin B-subunit
|
Lewis, David J.M. |
|
1993 |
11 |
2 |
p. 119-121 3 p. |
artikel |
10 |
Clinical trials of live oral rotavirus vaccines: the Finnish experience
|
Vesikari, Timo |
|
1993 |
11 |
2 |
p. 255-261 7 p. |
artikel |
11 |
Current progress in the development of the B subunits of cholera toxin and Escherichia coli heat-labile enterotoxin as carriers for the oral delivery of heterologous antigens and epitopes
|
Nashar, Toufic O. |
|
1993 |
11 |
2 |
p. 235-240 6 p. |
artikel |
12 |
Development of candidate rotavirus vaccines
|
Bishop, R.F. |
|
1993 |
11 |
2 |
p. 247-254 8 p. |
artikel |
13 |
DNA encoding glycophorin binding protein GBP130h from Plasmodium falciparum for use in malaria recombinant vaccine construction
|
|
|
1993 |
11 |
2 |
p. 284- 1 p. |
artikel |
14 |
Effect of parenteral immunization on the intestinal immune response to Salmonella typhi Ty21a as measured using peripheral blood lymphocytes
|
Forrest, Bruce D. |
|
1993 |
11 |
2 |
p. 136-139 4 p. |
artikel |
15 |
Epidemiology of diarrhoeal disease: implications for control by vaccines
|
Black, Robert E. |
|
1993 |
11 |
2 |
p. 100-106 7 p. |
artikel |
16 |
Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model
|
Mallett, C.P. |
|
1993 |
11 |
2 |
p. 190-196 7 p. |
artikel |
17 |
Homotypic and heterotypic immune responses to group A rotaviruses in parenterally immunized sheep
|
Beards, G.M. |
|
1993 |
11 |
2 |
p. 262-266 5 p. |
artikel |
18 |
Immune responses to hybrid maltose-binding proteins
|
O'Callaghan, David |
|
1993 |
11 |
2 |
p. 140-142 3 p. |
artikel |
19 |
Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradable microspheres of poly (lactide-co-glycolide)
|
Edelman, Robert |
|
1993 |
11 |
2 |
p. 155-158 4 p. |
artikel |
20 |
Induction of colonization factor antigen I (CFA/I) and coli surface antigen 4 (CS4) of enterotoxigenic Escherichia coli: relevance for vaccine production
|
Grewal, Harleen M.S. |
|
1993 |
11 |
2 |
p. 221-226 6 p. |
artikel |
21 |
Intestinal protection against challenge with transmissible gastroenteritis virus of pigs immune after infection with the porcine respiratory coronavirus
|
Cox, E. |
|
1993 |
11 |
2 |
p. 267-272 6 p. |
artikel |
22 |
Live oral vaccines against cholera: An update
|
Levine, Myron M. |
|
1993 |
11 |
2 |
p. 207-212 6 p. |
artikel |
23 |
Live, stable vaccine against colibacillosis in fowl; temperature-sensitive Escherichia coli mutant construction with low reversion frequency
|
|
|
1993 |
11 |
2 |
p. 284- 1 p. |
artikel |
24 |
New flagellum-less Borrelia and derived antigens; smooth Borrelia burgdoferi, Borrelia recurrentis, Borrelia hermsii, Borrelia turicatae, Borrelia duttoni, Borrelia persica, etc. may be used in a vaccine
|
|
|
1993 |
11 |
2 |
p. 283- 1 p. |
artikel |
25 |
Novel vaccination strategies for the control of mucosal infection
|
Husband, Alan J. |
|
1993 |
11 |
2 |
p. 107-112 6 p. |
artikel |
26 |
Pasteurella haemolytica glycoprotease gene and enzyme; use in cell surface glycoprotein deglycosylation, as a recombinant vaccine, etc.; DNA probe for Pasteurella haemolytica detection
|
|
|
1993 |
11 |
2 |
p. 284- 1 p. |
artikel |
27 |
Pili in microspheres protect rabbits from diarrhoea induced by E. coli strain RDEC-1
|
McQueen, C.E. |
|
1993 |
11 |
2 |
p. 201-206 6 p. |
artikel |
28 |
Preclinical evaluation of microencapsulated CFA/II oral vaccine against enterotoxigenic E. coli
|
Reid, R.H. |
|
1993 |
11 |
2 |
p. 159-167 9 p. |
artikel |
29 |
Recombinant enterotoxins as vaccines against Escherichia coli-mediated diarrhoea
|
Aitken, R. |
|
1993 |
11 |
2 |
p. 227-233 7 p. |
artikel |
30 |
Recombinant peptide and DNA; for tuberculosis diagnosis and as a vaccine against tuberculosis
|
|
|
1993 |
11 |
2 |
p. 284- 1 p. |
artikel |
31 |
Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in adult Vietnamese volunteers
|
Li, An |
|
1993 |
11 |
2 |
p. 180-189 10 p. |
artikel |
32 |
Shigella flexneri 2a and sonnei I vaccine with two attenuating markers: Construction, tolerability and immunogenicity in 143 children aged 3–17 years
|
Linde, K. |
|
1993 |
11 |
2 |
p. 197-200 4 p. |
artikel |
33 |
Stability, immunogenicity and expression of foreign antigens in bacterial vaccine vectors
|
Cárdenas, Lucia |
|
1993 |
11 |
2 |
p. 126-135 10 p. |
artikel |
34 |
Strategies for development of potential candidate Shigella vaccines
|
Lindberg, Alf A. |
|
1993 |
11 |
2 |
p. 168-179 12 p. |
artikel |
35 |
The conference on vaccines protective against enteric diseases
|
Spier, R.E. |
|
1993 |
11 |
2 |
p. 99- 1 p. |
artikel |
36 |
The PhoP virulence regulon and live oral Salmonella vaccines
|
Miller, Samuel I. |
|
1993 |
11 |
2 |
p. 122-125 4 p. |
artikel |
37 |
Treatment of autoimmune diseases e.g. rheumatoid arthritis; recombinant T-lymphocyte receptor peptide production; may be used for recombinant vaccine production, and rheumatoid arthritis, multiple sclerosis and autoimmune disease gene therapy
|
|
|
1993 |
11 |
2 |
p. 283- 1 p. |
artikel |
38 |
Vaccines for preventing enterotoxigenic Escherichia coli infections in farm animals
|
Moon, Harley W. |
|
1993 |
11 |
2 |
p. 213-220 8 p. |
artikel |